Cary, NC, United States of America

Ephraim L Tsalik

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 20(Granted Patents)


Location History:

  • Durham, NC (US) (2020)
  • Cary, NC (US) (2017 - 2024)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: **Ephraim L. Tsalik: Innovator in Sepsis Diagnosis and Treatment**

Introduction

Ephraim L. Tsalik is a notable inventor based in Cary, NC, recognized for his contributions to the fields of biomedical research and diagnostics. With a total of four patents to his name, Tsalik has made significant strides in understanding and treating sepsis, a life-threatening condition that requires prompt and accurate diagnosis.

Latest Patents

Among his latest innovations, Tsalik developed patents focusing on "Gene expression signatures useful to predict or diagnose sepsis and methods of using the same." These methodologies provide vital insights for determining whether a subject has sepsis or is at risk of developing it. Furthermore, his patented approaches offer means to assess an increased risk of mortality in patients with sepsis, providing essential data that can guide treatment decisions. The systems he has developed are pivotal for enhancing the management of this critical condition.

Career Highlights

Throughout his career, Ephraim L. Tsalik has worked with prestigious institutions, including Duke University and the Department of Veterans Affairs, representing the United States Government. His academic and professional experience has contributed to his understanding of complex biomedical challenges, solidifying his reputation as a key player in this field.

Collaborations

Tsalik has collaborated with esteemed colleagues such as Christopher W. Woods and Geoffrey S. Ginsburg. These partnerships have further facilitated advancements in research, particularly in the area of gene expression related to sepsis, showcasing the importance of teamwork in driving innovation forward.

Conclusion

Ephraim L. Tsalik's innovative work is instrumental in improving clinical outcomes for patients at risk of sepsis. His contributions through patents and collaborations reflect a dedication to scientific advancement and a commitment to addressing critical health challenges. As the medical community continues to evolve, Tsalik's discoveries will undoubtedly play a significant role in shaping future diagnostic and treatment strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…